Moderna

Open: 122.51 Close: 118.29 Change: -4.22

The 10 top things that an AI found about Moderna Stock and you do not know…

Are looking for the most relevant information about Moderna? Investor spend a lot of time searching for information to make investment decisions in Moderna. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Moderna are: Moderna, Chinese, China, develop, set, report, trading, and the most common words in the summary are: moderna, vaccine, stock, market, mrna, best, news, . One of the sentences in the summary was: Moderna closed at $123.54 in the latest trading session, marking a +1.49% move from …

Concept Map

Semantic Network

Stock Summary

Moderna, Inc. discovers, develops, and commercializes messenger RNA therapeutics and vaccines. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV.

Today's Summary

Moderna closed at $123.54 in the latest trading session, marking a +1.49% move from the prior day. Moderna is holding a Zacks Rank of #3 (Hold) right now.

Today's News

Moderna Inc. set to invest $1 billion in china, yicai reports. Moderna (NYSE:MRNA) Chooses to Cater to Chinese consumers. Moderna closed at $123.54 in the latest trading session, marking a +1.49% move from the prior day. Moderna is holding a Zacks Rank of #3 (Hold) right now. Moderna (NASDAQ: MRNA) has generated billions of dollars in sales and profit from its coronavirus vaccine. Chinese media outlet Yicai reported that Moderna was set to make its first investment in China. Moderna (MRNA) closed the most recent trading day at $123.54, moving +1.49% from the previous trading session. Moderna shares rose 1.5% on Wednesday after signing an agreement with China to research, develop, and make mRNA treatments there. The city government of Chinas financial hub Shanghai confirmed on Thursday the signing of strategic cooperation agreements with Moderna. Chinese media outlet Yicai reported on Tuesday that Moderna was set to make its first investment in China. US vaccine maker Moderna has signed a deal to research, develop, and manufacturer mRNA drugs in China. The Massachusetts-headquartered pharmaceutical firm could invest as much as $1 billion in China under the deal. Moderna struck a deal with Chinese officials to research, develop and manufacture messenger RNA medicines in the country. The Massachusetts-based biotech company will develop those drugs exclusively for the Chinese people, a spokesperson told CNBC. Moderna is trying to capitalize on the success of its Covid vaccine.

Stock Profile

"Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts."

Keywords

This document will help you to evaluate Moderna without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Moderna are: Moderna, Chinese, China, develop, set, report, trading, and the most common words in the summary are: moderna, vaccine, stock, market, mrna, best, news, . One of the sentences in the summary was: Moderna closed at $123.54 in the latest trading session, marking a +1.49% move from the prior day. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #moderna #vaccine #stock #market #mrna #best #news.